ReNeuron Group PLC (RQE)

London
9.04
-0.21(-2.27%)
  • Volume:
    7,230
  • Bid/Ask:
    9.00/9.50
  • Day's Range:
    9.04 - 9.04

RQE Overview

Prev. Close
9.25
Day's Range
9.04-9.04
Revenue
610K
Open
9.04
52 wk Range
8.5-44.5
EPS
-0.134
Volume
7,230
Market Cap
5.17M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
334,813
P/E Ratio
-0.69
Beta
0.904
1-Year Change
-70.63%
Shares Outstanding
57,173,760
Next Earnings Date
02 Jul 2023
What is your sentiment on ReNeuron?
or
Vote to see community's results!

ReNeuron Group PLC Company Profile

ReNeuron Group PLC Company Profile

ReNeuron Group plc is a United Kingdom-based Stem Cell and Exosome Technologies company that utilizes its stem cell technologies to develop treatments for disease with unmet needs. The Company’s stem cell derived Exosome Technology platform offers a delivery mechanism for a variety of payloads, such as small interfering Ribonucleic Acid (siRNA), messenger RNA (mRNA), proteins, small molecules and genes. The Company has two clinical-stage stem cell therapy candidate assets, a Phase 2a human retinal progenitor cell (hRPC) therapy candidate in retinitis pigmentosa and a Phase 2b immortalized neural progenitor cell therapy candidate (CTX) in stroke. The Company through its induced pluripotent stem cell (iPSC) platform has the ability to make allogeneic tissue cells of choice and has the potential to produce exosomes with tissue specific targeting ability.

Read More

Analyst Price Target

Average71.00 (+667.57% Upside)
High72.00
Low70.00
Price9.25
No. of Analysts2
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Analysts Consensus

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsSellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell